| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.3 | 0.04 |